<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813490892</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813490892</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sleep Medicine and Surgery</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Usefulness of Adenotonsillar Size for Prediction of Severity of Obstructive Sleep Apnea and Flow Limitation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hwang</surname><given-names>Se-Hwan</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599813490892">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Guilleminault</surname><given-names>Christian</given-names></name>
<degrees>MD, BiolD</degrees>
<xref ref-type="aff" rid="aff2-0194599813490892">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Park</surname><given-names>Chan-Soon</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-0194599813490892">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Tae-Won</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0194599813490892">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hong</surname><given-names>Seung-Chul</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-0194599813490892">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599813490892"><label>1</label>Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine, St Mary’s Hospital, Bucheon, South Korea</aff>
<aff id="aff2-0194599813490892"><label>2</label>Stanford University Sleep Medicine Division, Stanford University, School of Medicine, Stanford, California, USA</aff>
<aff id="aff3-0194599813490892"><label>3</label>Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine, St Vincent’s Hospital, Suwon, South Korea</aff>
<aff id="aff4-0194599813490892"><label>4</label>Department of Neuropsychiatry, The Catholic University of Korea, College of Medicine, St Vincent’s Hospital, Suwon, South Korea</aff>
<author-notes>
<corresp id="corresp1-0194599813490892">Chan-Soon Park, MD, PhD, Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine, St Vincent’s Hospital, Suwon, Ji-dong, Paldal-gu, Suwon City, 442-723, Republic of Korea. Email: <email>pcs0112@catholic.ac.kr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>149</volume>
<issue>2</issue>
<fpage>326</fpage>
<lpage>334</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>10</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>4</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>4</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599813490892">
<title>Objective</title>
<p>Adenotonsillar hypertrophy is considered the most common cause of pediatric obstructive sleep apnea syndrome (OSAS). This study aimed to evaluate the relationships between tonsil/adenoid size, parameters of polysomnography, and subjective sleep symptoms.</p>
</sec>
<sec id="section2-0194599813490892">
<title>Study Design</title>
<p>Case-control studies.</p>
</sec>
<sec id="section3-0194599813490892">
<title>Setting</title>
<p>Tertiary care center.</p>
</sec>
<sec id="section4-0194599813490892">
<title>Subjects and Methods</title>
<p>A 4-point tonsil grading method and adenoid-nasopharynx (AN) ratio were used to categorize tonsil and adenoid size, respectively. Sleep questionnaires (Korean version of the Obstructive Sleep Apnea–18 [KOSA-18]) and full-attended polysomnography were performed.</p>
</sec>
<sec id="section5-0194599813490892">
<title>Results</title>
<p>The subjects (n = 70) were divided into a control group (n = 31, apnea-hypopnea index [AHI] &lt;1) and an OSAS group (n = 39, AHI ≥1), which was subdivided into mild and moderate to severe groups. Tonsil/adenoid size showed a statistically significant difference between control and OSAS groups, but these differences had no clinical significance. In addition, tonsil/adenoid size did not differ significantly among 2 OSAS severity subgroups. Only adenoid size in the total and OSAS groups was related to quality of life (QOL) by the KOSA-18. The AN ratio was related to lowest oxygen saturation only in the OSAS group, especially in the moderate to severe OSAS group, but tonsil size was related to flow limitation in total and supine positions in the control group. In the control group, flow limitation was not associated with QOL.</p>
</sec>
<sec id="section6-0194599813490892">
<title>Conclusion</title>
<p>Tonsil/adenoid size did not predict the severity of AHI. Nevertheless, adenoid size might be related to lowest oxygen saturation, which is thought to be related to subjective symptoms. Although flow limitation was related to tonsil size but not to QOL in the control group, further research will be needed to understand the importance of flow limitation and upper airway resistance syndrome in the pediatric population.</p>
</sec>
</abstract>
<kwd-group>
<kwd>adenotonsillar hypertrophy</kwd>
<kwd>child</kwd>
<kwd>obstructive sleep apnea syndrome</kwd>
<kwd>polysomnography</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Obstructive sleep apnea syndrome (OSAS) in children is being recognized increasingly and receiving more attention. The prevalence of OSAS in the pediatric population is 2% to 4%.<sup><xref ref-type="bibr" rid="bibr1-0194599813490892">1</xref></sup> Adult OSAS is characterized by recurrent episodes of partial or complete upper airway obstruction during sleep, with increased respiratory effort; this characteristic of OSAS is also found in pediatric patients. However, pediatric OSAS has unique characteristics not seen in adult OSAS, such as hyperactivity, poor performance in school, and growth retardation.<sup><xref ref-type="bibr" rid="bibr2-0194599813490892">2</xref></sup></p>
<p>Hypertrophy of the adenoid and tonsils (ATH), narrowing the oropharyngeal airway, is considered one of the most common causes of pediatric OSAS and is associated with the fact that the facial bones grow more slowly than the lymphoid tissue, so the lymphoid tissue is relatively larger than the skeletal structures during childhood.<sup><xref ref-type="bibr" rid="bibr3-0194599813490892">3</xref>,<xref ref-type="bibr" rid="bibr4-0194599813490892">4</xref></sup></p>
<p>Although children with OSAS usually have larger tonsils and adenoids than those without OSAS, the diagnosis of pediatric OSAS cannot be made based only on the physical findings. Parental reports of nocturnal symptoms are also important (eg, habitual snoring, apneic events, unusual sleep position, and restless sleep). As in adults, overnight polysomnography (PSG) is the gold standard for diagnosis of OSAS in children. In addition, if PSG is not available, then clinicians may order alternative diagnostic tests, such as nocturnal video recording, nocturnal oximetry, or ambulatory PSG, which have been shown to have weaker positive and negative predictive values than PSG.<sup><xref ref-type="bibr" rid="bibr5-0194599813490892">5</xref></sup> However, pediatric sleep studies are not routinely performed because they are time-consuming and expensive. Another major reason is the lack of availability of sleep laboratories with the ability and desire to test children.</p>
<p>The sensitivity of the sleep history reported by the parents, such as snoring, is high in comparison with PSG-diagnosed OSAS, and the clinical usefulness of snoring is also high for clinical decision making for adenotonsillectomy in children.<sup><xref ref-type="bibr" rid="bibr6-0194599813490892">6</xref>,<xref ref-type="bibr" rid="bibr7-0194599813490892">7</xref></sup> However, the clinical usefulness of tonsil/adenoid size as a predictor of OSAS presence or severity is not clear despite its general use; indeed, previous studies have reported inconsistent results.</p>
<p>Moreover, it should be noted that sleep-disordered breathing (SDB) constitutes a wide spectrum, ranging from primary snoring or upper airway resistance syndrome (UARS) to OSAS. If patients with ATH show clinically definite symptoms of OSAS such as witnessed apnea, the clinical utility of tonsil/adenoid size as a predictor of OSAS may be high. However, if patients do not have definite ATH or show clinically definite symptoms of OSAS, it poses an interesting question of what a diagnosis of SDB should be based on. This question is the main purpose of this current study.</p>
<p>Upper airway resistance syndrome is defined as symptoms associated with SDB, increased intrathoracic pressure, and an increased frequency of respiratory effort–related arousals (RERA) but without sufficient apneas/hypopneas associated with OSAS.<sup><xref ref-type="bibr" rid="bibr8-0194599813490892">8</xref></sup> According to the American Academy of Sleep Medicine (AASM) manual for the scoring of sleep and associated events, RERA can be scored with an esophageal manometry or nasal pressure transducer showing flattening of the nasal pressure waveform.<sup><xref ref-type="bibr" rid="bibr9-0194599813490892">9</xref></sup> During periods of partial collapse of the airway, the inspiratory flow signal shows a flattening of nasal flow with a nasal pressure transducer, which identifies flow limitation and elevated upper airway resistance.<sup><xref ref-type="bibr" rid="bibr10-0194599813490892">10</xref></sup> For accuracy, an esophageal manometry may be superior to a nasal pressure transducer, but the insertion of an esophageal manometry is not always easy, especially in pediatric subjects.</p>
<p>This study assessed 70 children preoperatively in terms of tonsil size, adenoid hypertrophy, adenoid-nasopharynx ratio, and sleep questionnaires. Subjects were then evaluated by overnight PSG. In this study, we tried to evaluate the usefulness of ATH as a clinical diagnosis of SDB, including OSAS, on the basis of subjective (questionnaires) and objective (PSG) point of view. Our study focused on the relationships between tonsil/adenoid size and parameters of PSG, such as the apnea-hypopnea index (AHI) and flow limitation, or quality of life (QOL) related to sleep symptoms.</p>
<sec id="section7-0194599813490892" sec-type="methods">
<title>Patients and Methods</title>
<sec id="section8-0194599813490892">
<title>Subjects</title>
<p>Seventy children who attended our clinic with suspected OSAS between July 2011 and February 2012 were enrolled in this study prospectively. Exclusion criteria included a history of tonsillectomy, congenital disorders, Down’s syndrome, neuromuscular disease, chronic lung disease, and craniofacial abnormalities. All children underwent a physical examination, had standard lateral neck radiographs or cephalometry taken, completed a sleep questionnaire (the Korean version of the Obstructive Sleep Apnea–18 [KOSA-18]), and underwent PSG.</p>
<p>The study was explained to all participants and their parents, and then informed consent was obtained from the participants’ mother or father before PSG. The study protocol was reviewed and approved by the Ethics Committee for Clinical Studies at St Vincent’s Hospital, The Catholic University of Korea.</p>
</sec>
<sec id="section9-0194599813490892">
<title>Tonsil Size</title>
<p>The tonsil size were measured as a sum of each subjective tonsil size scale<sup><xref ref-type="bibr" rid="bibr11-0194599813490892">11</xref></sup> by 1 doctor (CS Park) because some subjects had asymmetric tonsillar sizes: grade 1, the tonsil was totally in the tonsillar fossa and hidden behind the anterior pillar; grade 2, the tonsil was in the tonsillar fossa and extended to the posterior pillar; grade 3, the tonsil was out of the tonsillar fossa but did not extend across the midline between the posterior pillar and midpoint of the soft palate (uvula); and grade 4, the tonsil extended across the midline between the posterior pillar and uvula or attached to the other tonsil in the midline. The sum of the 2 tonsil sizes was used as the tonsil size.</p>
</sec>
<sec id="section10-0194599813490892">
<title>Adenoid Size</title>
<p>To evaluate adenoid size, we measured the adenoid-nasopharynx ratio (AN ratio) in the lateral neck radiograph or by cephalometry, as described by Fujioka et al.<sup><xref ref-type="bibr" rid="bibr12-0194599813490892">12</xref></sup> Briefly, adenoid measurement (A) was measured along the line perpendicular to point A′ (the maximal convexity along the inferior margin of the adenoid shadow) to its intersection, with line B drawn along the straight part of the anterior margin of the basiocciput (<xref ref-type="fig" rid="fig1-0194599813490892"><bold>Figure 1</bold></xref>). The nasopharyngeal space (N) was measured as the distance between the posterosuperior edge of the hard palate and anteroinferior edge of the sphenobasioccipital synchondrosis. The AN ratio was calculated by dividing A by N.</p>
<fig id="fig1-0194599813490892" position="float">
<label>Figure 1.</label>
<caption>
<p>Calculation of the adenoidal-nasopharyngeal ratio by dividing the distance from the outermost point of convexity of the adenoid shadow (A) to the straight part of the anterior margin of the basicocciput (P) to the distance between sphenobasiocciput and posterior end of the hard palate (N).</p>
</caption>
<graphic xlink:href="10.1177_0194599813490892-fig1.tif"/>
</fig>
</sec>
<sec id="section11-0194599813490892">
<title>Questionnaires</title>
<p>After completing a thorough physical examination and structured interview, all of the participants’ parents completed the sleep questionnaire, the KOSA-18, for sleep quality.</p>
</sec>
<sec id="section12-0194599813490892">
<title>Polysomnography</title>
<p>Fully attended PSG was performed, which included a preestablished montage of 4-lead electroencephalography (EEG), electrocardiography, 2-lead electro-oculography, submental electromyography (EMG), bilateral anterior tibialis EMG, fingertip pulse oximetry, snore sensor, nasal and oral airflow, and chest and abdominal movement; airflow through the nose was measured with a nasal pressure transducer and thermistor. All measured parameters, which were digitized and recorded with Somnologica software and Embla S700/A10 hardware (Embla System, Broomfield, Colorado), were scored initially by a certified technician and then reviewed by a doctor (CS Park). The respiratory parameters were scored using standards set by the AASM manual for the scoring of sleep and associated events and the American Thoracic Society.<sup><xref ref-type="bibr" rid="bibr8-0194599813490892">8</xref>,<xref ref-type="bibr" rid="bibr13-0194599813490892">13</xref></sup> The AHI was defined as the average number of obstructive and mixed apnea and hypopnea per hour. The diagnostic criterion for pediatric obstructive sleep apnea (OSA) was defined as AHI ≥1 event/h. Apnea was defined as the absence or reduction of &gt;90% of oronasal airflow for &gt;90% of the entire event, which lasted for at least 2 regular breaths, compared with the previous baseline amplitude. Obstructive hypopnea was defined as a 50% airflow reduction or more for &gt;90% of the entire event, which lasted for at least 2 regular breaths with a desaturation of 3% or greater on awakening or EEG arousal (compared with the previous baseline amplitude).</p>
<p>The presence of flow limitations was confirmed by 1 doctor (CS Park), and the percentage of inspiratory flow limitation (flow limitation index, breaths with inspiratory flow limitation/total breaths) was calculated automatically with Somnologica software.</p>
</sec>
<sec id="section13-0194599813490892">
<title>Statistics</title>
<p>The data are presented as the means ± standard deviations. To assess the normality of the data, the Shapiro-Wilk test was performed before further analysis. Quantitative variables in the case (AHI ≥1) and control (AHI &lt;1) groups were compared using the <italic>t</italic> test or Wilcoxon rank-sum test. Correlations between subjective symptoms and ATH/parameters of PSG were analyzed with the Pearson or Spearman test.</p>
<p>Statistical analyses were performed with SPSS version 10.1 (SPSS, Inc, an IBM Company, Chicago, Illinois). Differences were considered significant at <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section14-0194599813490892" sec-type="results">
<title>Results</title>
<p>The subjects (n = 70) were divided into control (AHI &lt;1) and OSAS (AHI ≥1) groups. The demographic data and PSG findings are presented in <xref ref-type="table" rid="table1-0194599813490892"><bold>Table 1</bold></xref>. The OSAS group included 28 males (71.8%) and 11 females (28.2%), which had more males than did the control group (14 males [45.2%] and 17 females [54.8%]). There was no significant difference in body mass index between the 2 groups. The AHI and total and nonsupine flow limitation in the OSAS group were significantly higher than in controls. The QOL score was 68.3 ± 19.6 for the OSAS group and 54.5 ± 14.7 for controls (ie, the QOL was significantly lower in the OSAS group). The tonsil size was significantly greater in the OSAS group (6.1 ± 1.3 vs 5.3 ± 1.5). The AN ratio was significantly higher in the OSAS group (0.7 ± 0.1 vs 0.6 ± 0.1).</p>
<table-wrap id="table1-0194599813490892" position="float">
<label>Table 1.</label>
<caption>
<p>Anthropometrics and characteristics of subjects.</p>
</caption>
<graphic alternate-form-of="table1-0194599813490892" xlink:href="10.1177_0194599813490892-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Total (n = 70)</th>
<th align="center">Control (n = 31)</th>
<th align="center">OSAS (n = 39)</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">Sex</td>
</tr>
<tr>
<td> Male</td>
<td>42 (60.0)</td>
<td>14 (45.2)</td>
<td>28 (71.8)</td>
<td rowspan="2" valign="top">.024</td>
</tr>
<tr>
<td> Female</td>
<td>28 (40.0)</td>
<td>17 (54.8)</td>
<td>11 (28.2)</td>
</tr>
<tr>
<td>Age, y</td>
<td>7.2 ± 2.8</td>
<td>7.6 ± 2.6</td>
<td>6.8 ± 3.0</td>
<td>.245</td>
</tr>
<tr>
<td>BMI</td>
<td>18.6 ± 3.9</td>
<td>18.6 ± 3.5</td>
<td>18.6 ± 4.3</td>
<td>.987</td>
</tr>
<tr>
<td>Tonsil</td>
<td>5.7 ± 1.4</td>
<td>5.3 ± 1.5</td>
<td>6.1 ± 1.3</td>
<td>.011<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>AN_r</td>
<td>0.6 ± 0.1</td>
<td>0.6 ± 0.1</td>
<td>0.7 ± 0.1</td>
<td>.040<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>AHI</td>
<td>6.9 ± 11.3</td>
<td>0.2 ± 0.3</td>
<td>12.4 ± 12.8</td>
<td>&lt;.0001<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td> 0 to &lt;1</td>
<td>31 (44.9)</td>
<td>31 (100.0)</td>
<td>0</td>
<td>&lt;.0001<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td> 1 to &lt;5</td>
<td>16 (23.2)</td>
<td>0</td>
<td>17 (43.6)</td>
<td/>
</tr>
<tr>
<td> 5 to &lt;10</td>
<td>6 (8.7)</td>
<td>0</td>
<td>6 (15.4)</td>
<td/>
</tr>
<tr>
<td> ≥10</td>
<td>16 (23.2)</td>
<td>0</td>
<td>16 (41.0)</td>
<td/>
</tr>
<tr>
<td>AHI_s</td>
<td>11.0 ± 24.8</td>
<td>0.1 ± 0.2</td>
<td>19.7 ± 30.7</td>
<td>.0003<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>AHI_ns</td>
<td>15.4 ± 27.6</td>
<td>0.7 ± 1.3</td>
<td>27.1 ± 32.7</td>
<td>&lt;.0001<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>FLI_t</td>
<td>18.0 ± 16.5</td>
<td>14.7 ± 16.5</td>
<td>20.7 ± 16.2</td>
<td>.136</td>
</tr>
<tr>
<td>FLI_S</td>
<td>19.6 ± 19.0</td>
<td>18.3 ± 22.0</td>
<td>20.7 ± 16.4</td>
<td>.613</td>
</tr>
<tr>
<td>FLI_ns</td>
<td>16.3 ± 17.7</td>
<td>9.9 ± 13.3</td>
<td>21.6 ± 19.3</td>
<td>.004<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>REM_index</td>
<td>14.6 ± 23.4</td>
<td>1.0 ± 1.5</td>
<td>25.6 ± 27.0</td>
<td>&lt;.0001<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>NREM_index</td>
<td>5.2 ± 9.9</td>
<td>0.1 ± 0.2</td>
<td>9.3 ± 11.8</td>
<td>&lt;.0001<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>ODI</td>
<td>4.1 ± 7.6</td>
<td>0.3 ± 0.2</td>
<td>6.3 ± 8.9</td>
<td>.0005<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>LSaO<sub>2</sub>
</td>
<td>89.2 ± 12.5</td>
<td>89.3 ± 17.3</td>
<td>89.1 ± 6.9</td>
<td>.946</td>
</tr>
<tr>
<td>QOL_total</td>
<td>61.7 ± 18.6</td>
<td>54.5 ± 14.7</td>
<td>68.3 ± 19.6</td>
<td>.006<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490892">a</xref></sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599813490892">
<p>Values are presented as mean ± SD (<italic>t</italic> test) or No. (%) (χ<sup>2</sup> or Fisher exact test). Abbreviations: AHI, apnea-hypopnea index; AHI_ns, apnea-hypopnea index in nonsupine position; AHI_s, apnea-hypopnea index in supine position; AN_r, adenoid-nasopharynx ratio; BMI, body mass index; FLI_ns, nonsupine flow limitation; FLI_S, supine flow limitation; FLI_t, total flow limitation; LSaO<sub>2</sub>, lowest arterial oxygen saturation; NREM, nonrapid eye movement; ODI, oxygen desaturation index &gt;3%; OSAS, obstructive sleep apnea syndrome; QOL, quality of life (Korean version of the Obstructive Sleep Apnea–18); REM, rapid eye movement.</p>
</fn>
<fn id="table-fn2-0194599813490892">
<label>a</label>
<p><italic>P</italic> value &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The OSAS group (n = 39) was further subdivided into 2 groups, with mild (n = 17, 43.6%; AHI, 1 to &lt;5) and moderate to severe (n = 22, 56.4%; AHI, ≥5) OSAS. Although the adenotonsillar size was statistically larger in the OSAS group than in control group, it was not clinically different among control and OSAS groups (0.6 vs 0.7 in the AN ratio, 5.3 vs 6.1 in tonsil size). Tonsil size and the AN ratio did not differ significantly among 2 OSAS subgroups (<xref ref-type="table" rid="table2-0194599813490892"><bold>Table 2</bold></xref>).</p>
<table-wrap id="table2-0194599813490892" position="float">
<label>Table 2.</label>
<caption>
<p>Tonsil and adenoid size (adenoid-nasopharynx ratio) according to OSA severity.</p>
</caption>
<graphic alternate-form-of="table2-0194599813490892" xlink:href="10.1177_0194599813490892-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Control (n = 31)</th>
<th align="center">Mild (n = 17)</th>
<th align="center">Moderate to Severe (n = 22)</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">Tonsil</td>
</tr>
<tr>
<td> Median (range)</td>
<td>6.0 (2.0-8.0)</td>
<td>6.0 (4.0-8.0)</td>
<td>6.0 (4.0-8.0)</td>
<td>.790</td>
</tr>
<tr>
<td> Mean ± SD</td>
<td>5.3 ± 1.5</td>
<td>6.0 ± 1.2</td>
<td>6.2 ± 1.3</td>
<td>.819</td>
</tr>
<tr>
<th/>
<th align="center">Control (n = 26)</th>
<th align="center">Mild (n = 14)</th>
<th align="center">Moderate to Severe (n = 21)</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
<tr>
<td colspan="5">AN_r</td>
</tr>
<tr>
<td> Median (range)</td>
<td>0.6 (0.4-0.9)</td>
<td>0.6 (0.4-0.9)</td>
<td>0.7 (0.5-0.9)</td>
<td>.480</td>
</tr>
<tr>
<td> Mean ± SD</td>
<td>0.6 ± 0.1</td>
<td>0.6 ± 0.1</td>
<td>0.7 ± 0.1</td>
<td>.495</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0194599813490892">
<p>Median (range) tested by the Kruskal-Willis test. Mean ± SD tested by analysis of variance. Abbreviations: AN_r, adenoid-nasopharynx ratio; OSA, obstructive sleep apnea.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The AHI was correlated with the subjective symptom score (KOSA-18, <italic>r</italic> = 0.341, <italic>P</italic> = .029) in the total group, whereas the AHI according to position (supine vs nonsupine) had a weak positive correlation with the KOSA-18 (<italic>r</italic> = 0.304 in supine, <italic>r</italic> = 0.247 in nonsupine), without statistical significance (<xref ref-type="table" rid="table3-0194599813490892"><bold>Table 3</bold></xref>).</p>
<table-wrap id="table3-0194599813490892" position="float">
<label>Table 3.</label>
<caption>
<p>Correlation of AHI with QOL in the total group.</p>
</caption>
<graphic alternate-form-of="table3-0194599813490892" xlink:href="10.1177_0194599813490892-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="center" colspan="2">QOL<hr/></th>
</tr>
<tr>
<th/>
<th align="center">n</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>AHI</td>
<td>52</td>
<td>0.341</td>
<td>.029<sup><xref ref-type="table-fn" rid="table-fn5-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>AHI_s</td>
<td>52</td>
<td>0.304</td>
<td>.076</td>
</tr>
<tr>
<td>AHI_ns</td>
<td>52</td>
<td>0.247</td>
<td>.140</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599813490892">
<p>Pearson correlation after log transfer (QOL, AHI, AHI_s, AHI_ns). Abbreviations: AHI, apnea-hypopnea index; AHI_ns, apnea-hypopnea index in nonsupine position; AHI_s, apnea-hypopnea index in supine position; QOL, quality of life (Korean version of the Obstructive Sleep Apnea–18).</p>
</fn>
<fn id="table-fn5-0194599813490892">
<label>a</label>
<p><italic>P</italic> value &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although the adenoid and tonsil size were positively related to AHI in the total group (<xref ref-type="fig" rid="fig2-0194599813490892"><bold>Figure 2</bold></xref>), only adenoid size (not tonsil size) in the total and OSAS groups was related to the symptom score (KOSA-18, <italic>r</italic> = 0.490, <italic>P</italic> = .001 in the total group; <italic>r</italic> = 0.502, <italic>P</italic> = .015 in the OSAS group) (<xref ref-type="table" rid="table4-0194599813490892"><bold>Table 4</bold></xref>). This might be explained by the fact that adenoid size (AN ratio) was related to the lowest oxygen saturation only in the OSAS group, especially in the moderate to severe OSAS subgroup, but not to the oxygen desaturation index (ODI) (<xref ref-type="table" rid="table5-0194599813490892"><bold>Table 5</bold></xref>).</p>
<fig id="fig2-0194599813490892" position="float">
<label>Figure 2.</label>
<caption>
<p>Correlation of the tonsil size (A) and the adenoid-nasopharynx ratio (AN_r) (B) with the apnea-hypopnea index (AHI) in the total group (n = 70).</p>
</caption>
<graphic xlink:href="10.1177_0194599813490892-fig2.tif"/>
</fig>
<table-wrap id="table4-0194599813490892" position="float">
<label>Table 4.</label>
<caption>
<p>Correlation of adenotonsillar size with QOL.</p>
</caption>
<graphic alternate-form-of="table4-0194599813490892" xlink:href="10.1177_0194599813490892-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="3">Tonsil<hr/></th>
<th align="center" colspan="3">AN_r<hr/></th>
</tr>
<tr>
<th align="left">QOL</th>
<th align="center">n</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">n</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total</td>
<td>52</td>
<td>0.056</td>
<td>.695</td>
<td>44</td>
<td>0.490</td>
<td>.001<sup><xref ref-type="table-fn" rid="table-fn7-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td>Control (n = 31)</td>
<td>25</td>
<td>0.174</td>
<td>.404</td>
<td>21</td>
<td>0.432</td>
<td>.050</td>
</tr>
<tr>
<td>Case (n = 39)</td>
<td>27</td>
<td>−0.306</td>
<td>.120</td>
<td>23</td>
<td>0.502</td>
<td>.015<sup><xref ref-type="table-fn" rid="table-fn7-0194599813490892">a</xref></sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0194599813490892">
<p>Spearman correlation. Abbreviations: AN_r, adenoid-nasopharynx ratio; QOL, quality of life (Korean version of the Obstructive Sleep Apnea–18).</p>
</fn>
<fn id="table-fn7-0194599813490892">
<label>a</label>
<p><italic>P</italic> value &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table5-0194599813490892" position="float">
<label>Table 5.</label>
<caption>
<p>Correlation of adenotonsillar size with oxygen desaturation.</p>
</caption>
<graphic alternate-form-of="table5-0194599813490892" xlink:href="10.1177_0194599813490892-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="3">ODI<hr/></th>
<th align="center" colspan="3">LSaO<sub>2</sub>
<hr/></th>
</tr>
<tr>
<th/>
<th align="center">n</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">n</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="7">Total (n = 70)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>52</td>
<td>0.192</td>
<td>.172</td>
<td>70</td>
<td>−0.154</td>
<td>.202</td>
</tr>
<tr>
<td> AN_r</td>
<td>46</td>
<td>0.225</td>
<td>.132</td>
<td>61</td>
<td>−0.239</td>
<td>.063</td>
</tr>
<tr>
<td colspan="7">Control (n = 31)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>19</td>
<td>−0.061</td>
<td>.804</td>
<td>31</td>
<td>−0.223</td>
<td>.228</td>
</tr>
<tr>
<td> AN_r</td>
<td>16</td>
<td>0.308</td>
<td>.246</td>
<td>26</td>
<td>−0.025</td>
<td>.902</td>
</tr>
<tr>
<td colspan="7">Case (n = 39)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>33</td>
<td>0.162</td>
<td>.369</td>
<td>39</td>
<td>0.048</td>
<td>.771</td>
</tr>
<tr>
<td> AN_r</td>
<td>30</td>
<td>0.086</td>
<td>.650</td>
<td>35</td>
<td>−0.350</td>
<td>.039<sup><xref ref-type="table-fn" rid="table-fn9-0194599813490892">a</xref></sup>
</td>
</tr>
<tr>
<td colspan="7">Control (n = 31)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>19</td>
<td>−0.061</td>
<td>.804</td>
<td>31</td>
<td>−0.223</td>
<td>.228</td>
</tr>
<tr>
<td> AN_r</td>
<td>16</td>
<td>0.308</td>
<td>.246</td>
<td>26</td>
<td>−0.025</td>
<td>.902</td>
</tr>
<tr>
<td colspan="7">Mild (n = 17)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>12</td>
<td>−0.234</td>
<td>.463</td>
<td>17</td>
<td>0.122</td>
<td>.641</td>
</tr>
<tr>
<td> AN_r</td>
<td>10</td>
<td>0.019</td>
<td>.959</td>
<td>14</td>
<td>0.009</td>
<td>.976</td>
</tr>
<tr>
<td colspan="7">Moderate to severe (n = 22)</td>
</tr>
<tr>
<td> Tonsil</td>
<td>22</td>
<td>0.291</td>
<td>.201</td>
<td>6</td>
<td>0.060</td>
<td>.792</td>
</tr>
<tr>
<td> AN_r</td>
<td>21</td>
<td>0.231</td>
<td>.327</td>
<td>6</td>
<td>−0.534</td>
<td>.013<sup><xref ref-type="table-fn" rid="table-fn9-0194599813490892">a</xref></sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0194599813490892">
<p>Abbreviations: AN_r, adenoid-nasopharynx ratio; LSaO<sub>2</sub>, lowest arterial oxygen saturation; ODI, oxygen desaturation index &gt;3%.</p>
</fn>
<fn id="table-fn9-0194599813490892">
<label>a</label>
<p><italic>P</italic> value &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The relationship between adenotonsillar size and flow limitation in each group was analyzed (<xref ref-type="table" rid="table6-0194599813490892"><bold>Table 6</bold></xref>). Although there was a significant difference in flow limitation between control and OSAS groups, a correlation between tonsil size (not adenoid size) and flow limitation was seen only in the total and supine positions in the control group (<xref ref-type="table" rid="table6-0194599813490892"><bold>Table 6</bold></xref>). However, the flow limitation in those positions was not correlated with subjective symptom. In the control group, the flow limitation was not associated with the QOL (KOSA-18) (<xref ref-type="table" rid="table7-0194599813490892"><bold>Table 7</bold></xref>).</p>
<table-wrap id="table6-0194599813490892" position="float">
<label>Table 6.</label>
<caption>
<p>Correlation of adenotonsillar size with flow limitation according to obstructive sleep apnea severity.</p>
</caption>
<graphic alternate-form-of="table6-0194599813490892" xlink:href="10.1177_0194599813490892-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="4">Control (AHI &lt;1)<hr/></th>
</tr>
<tr>
<th/>
<th align="center" colspan="2">Tonsil (n = 31)<hr/></th>
<th align="center" colspan="2">AN_r (n = 26)<hr/></th>
</tr>
<tr>
<th/>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>FLI_t</td>
<td>0.362</td>
<td>.045<sup><xref ref-type="table-fn" rid="table-fn11-0194599813490892">a</xref></sup>
</td>
<td>0.215</td>
<td>.291</td>
</tr>
<tr>
<td>FLI_S</td>
<td>0.536</td>
<td>.002<sup><xref ref-type="table-fn" rid="table-fn11-0194599813490892">a</xref></sup>
</td>
<td>0.230</td>
<td>.258</td>
</tr>
<tr>
<td>FLI_ns</td>
<td>0.293</td>
<td>.110</td>
<td>0.154</td>
<td>.454</td>
</tr>
<tr>
<th/>
<th align="center" colspan="4">Mild (AHI 1 to &lt;5)<hr/></th>
</tr>
<tr>
<th/>
<th align="center" colspan="2">Tonsil (n = 17)<hr/></th>
<th align="center" colspan="2">AN_r (n = 14)<hr/></th>
</tr>
<tr>
<th/>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
<tr>
<td>FLI_t</td>
<td>0.081</td>
<td>.758</td>
<td>0.443</td>
<td>.113</td>
</tr>
<tr>
<td>FLI_S</td>
<td>0.081</td>
<td>.758</td>
<td>0.370</td>
<td>.192</td>
</tr>
<tr>
<td>FLI_ns</td>
<td>0.162</td>
<td>.535</td>
<td>0.419</td>
<td>.136</td>
</tr>
<tr>
<th/>
<th align="center" colspan="4">Moderate to Severe (AHI ≥5)<hr/></th>
</tr>
<tr>
<th/>
<th align="center" colspan="2">Tonsil (n = 22)<hr/></th>
<th align="center" colspan="2">AN_r (n = 21)<hr/></th>
</tr>
<tr>
<th/>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
<tr>
<td>FLI_t</td>
<td>0.273</td>
<td>.305</td>
<td>0.079</td>
<td>.734</td>
</tr>
<tr>
<td>FLI_S</td>
<td>0.097</td>
<td>.721</td>
<td>0.067</td>
<td>.773</td>
</tr>
<tr>
<td>FLI_ns</td>
<td>0.329</td>
<td>.214</td>
<td>−0.018</td>
<td>.940</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-0194599813490892">
<p>Spearman correlation. Abbreviations: AHI, apnea-hypopnea index; AN_r, adenoid-nasopharynx ratio; FLI_ns, nonsupine flow limitation; FLI_S, supine flow limitation; FLI_t, total flow limitation.</p>
</fn>
<fn id="table-fn11-0194599813490892">
<label>a</label>
<p><italic>P</italic> value &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table7-0194599813490892" position="float">
<label>Table 7.</label>
<caption>
<p>Correlation of flow limitation with daytime sleepiness and quality of life in the control group.</p>
</caption>
<graphic alternate-form-of="table7-0194599813490892" xlink:href="10.1177_0194599813490892-table7.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Control (AHI &lt;1)<hr/></th>
</tr>
<tr>
<th/>
<th align="center" colspan="2">QOL (n = 13)<hr/></th>
</tr>
<tr>
<th/>
<th align="center">
<italic>r</italic>
</th>
<th align="center">
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>FLI_t</td>
<td>0.232</td>
<td>.265</td>
</tr>
<tr>
<td>FLI_S</td>
<td>0.149</td>
<td>.476</td>
</tr>
<tr>
<td>FLI_ns</td>
<td>0.345</td>
<td>.092</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn12-0194599813490892">
<p>Spearman correlation. Abbreviations: AHI, apnea-hypopnea index; FLI_ns, nonsupine flow limitation; FLI_S, supine flow limitation; FLI_t, total flow limitation; QOL, quality of life (Korean version of the Obstructive Sleep Apnea–18).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section15-0194599813490892" sec-type="discussion">
<title>Discussion</title>
<p>Although overnight PSG is the gold standard for diagnosis of OSAS in children, as in adults, the decision to perform an adenotonsillectomy is usually based on physical findings such as adenotonsillar hypertrophy and parental reports. However, even if PSG is performed, the AHI itself (the parameter that is usually used for OSAS) cannot explain all aspects of SDB, including primary snoring, UARS, and OSAS.</p>
<p>In 1993, Guilleminault et al<sup><xref ref-type="bibr" rid="bibr14-0194599813490892">14</xref></sup> reported UARS. The arousals induced by repetitive increases in respiratory effort with this syndrome might lead to symptoms such as daytime sleepiness and functional impairment. The diagnostic criteria of UARS include RERA and clinical symptoms due to abnormal sleep but do not also meet the definitions of AHI for OSAS. In a long-term outcome study, Guilleminault et al<sup><xref ref-type="bibr" rid="bibr15-0194599813490892">15</xref></sup> showed that sleep fragmentation and daytime symptoms increased over time, and there was no spontaneous remission of symptoms if the UARS was not treated. They also suggested that the likelihood of insomnia, daytime fatigue, or depressive mood increased by 12 to 20 times over a 4-year period. Therefore, the International Classification of Sleep Disorders II (ICSD II) recommends that UARS should be included as a part of OSA.<sup><xref ref-type="bibr" rid="bibr16-0194599813490892">16</xref></sup></p>
<p>However, the major dilemma in this field currently is that the so-called gold standard diagnostic test (polysomnography) fails to easily identify children with UARS and/or RERA without esophageal manometry by all scorers. To date, there has been no widely accepted consensus about validated standard methods to identify RERA with high interscorer reliability,<sup><xref ref-type="bibr" rid="bibr17-0194599813490892">17</xref>,<xref ref-type="bibr" rid="bibr18-0194599813490892">18</xref></sup> but in 2012, the AASM approved the scoring of RERA with increased respiratory efforts (esophageal manometry) or flattening of the inspiratory portion of the nasal pressure (flow limitation) leading to arousal on PSG.<sup><xref ref-type="bibr" rid="bibr19-0194599813490892">19</xref></sup> Flow limitation itself cannot mean RERA, but it can be said that the more flow limitations, the higher the possibility of RERA. In addition, it should be noted that there have been controversies over the existence of UARS as a distinct disease entity, and further evaluation will be needed to apply our result to pediatric subjects because of the modest size of the study population.</p>
<p>Although more comprehensive questionnaires have been developed recently, the usefulness and thresholds of screening questionnaires for pediatric subjects remain controversial. We used a sleep questionnaire with published validity and usefulness for sleep quality: the KOSA-18.<sup><xref ref-type="bibr" rid="bibr18-0194599813490892">18</xref></sup></p>
<p>The evaluation of the correlation between AHI according to position and subjective symptoms demonstrated that although the AHI was correlated with subjective symptom scores, the AHI according to position had no significant correlation with symptoms, which might be explained by a previous study showing that sleep position in children with OSAS did not affect their sleep architecture,<sup><xref ref-type="bibr" rid="bibr20-0194599813490892">20</xref></sup> although the AHI could be changed according to position change.</p>
<p>We used the modified tonsil grading method (a sum of each subjective tonsil size scale) because the method classifies tonsils according to tonsil extension to the pillars and midline, which are relatively simple and fixed standards, and provides more consistent evaluation of the tonsils, irrespective of the clinician.<sup><xref ref-type="bibr" rid="bibr11-0194599813490892">11</xref>,<xref ref-type="bibr" rid="bibr21-0194599813490892">21</xref></sup></p>
<p>Similar to our results, a previous study showed that although adenoid and tonsil size did not predict the number of apneas, a significant relationship was seen between only adenoid size and the duration of obstructive apneas, and adenoid size contributed to the lowest oxyhemoglobin saturation, with a correlation coefficient (<italic>r</italic>) of 0.69.<sup><xref ref-type="bibr" rid="bibr22-0194599813490892">22</xref></sup></p>
<p>In our study, adenoid and tonsil size were greater in the OSAS group than in the control group, and there was a positive correlation between ATH and AHI in the total group. However, these statistical differences in adenoid and tonsil size between control and OSAS groups might not have a clinical significance. In addition, there was no significant difference between OSAS severity subgroups in adenoid and tonsil size, which was similar to previous results that adenoid and tonsil size did not predict the number of apneas.<sup><xref ref-type="bibr" rid="bibr22-0194599813490892">22</xref></sup></p>
<p>The relationship between ATH and AHI in the total group would be caused by the result that ATH was greater in the OSAS group than in the control group. In addition, only adenoid size (not tonsil size) was related to subjective symptom scores in all participants and OSAS groups, and the lowest oxygen saturation was related to only the OSAS group. This could be explained by the previous study showing that only adenoid size had a significant relationship with the duration of apneas and lowest oxyhemoglobin saturation.<sup><xref ref-type="bibr" rid="bibr22-0194599813490892">22</xref></sup></p>
<p>Persak et al<sup><xref ref-type="bibr" rid="bibr23-0194599813490892">23</xref></sup> suggested that the collapsing airway geometry in the pharyngeal airway was different between OSAS and control pediatric subjects, which was explained by the computational fluid dynamics model. In their study, OSAS subjects had higher compliance in the pharyngeal airway during inspiration, with each OSAS subject having a unique compliance curve, whereas control subjects had very low compliance in the oropharynx; the nasopharynx was always less compliant than the oropharynx.</p>
<p>In our study, the relationship between tonsillar size and flow limitation was observed only in the total and supine position of the control group. However, a correlation between ATH and flow limitation was not observed in the OSAS group (<xref ref-type="table" rid="table6-0194599813490892"><bold>Table 6</bold></xref>). Considering that there was a difference between the OSAS and control groups in compliance of the pharyngeal airway, the best explanation for this may be that an anatomic factor such as tonsil size may be related to RERA (and finally to UARS) in the control group (AHI &lt;1). It was reported that the AHI and desaturation time were significantly higher in the supine compared with the lateral position.<sup><xref ref-type="bibr" rid="bibr24-0194599813490892">24</xref>,<xref ref-type="bibr" rid="bibr25-0194599813490892">25</xref></sup> This would mean that the narrowing of the pharyngeal airway due to the volume effect of tonsils in the supine position could cause abnormal breathing patterns that could not be scored as hypopnea and apnea in the control group.</p>
<p>The OSA-18 is a reliable method of determining the quality-of-life impact from SDB.<sup><xref ref-type="bibr" rid="bibr18-0194599813490892">18</xref></sup> Although our result did not show that flow limitation has no association with any clinical outcomes (KOSA-18) in the control group (<xref ref-type="table" rid="table7-0194599813490892"><bold>Table 7</bold></xref>), it should be noted that chronic snorers who have no apneas, hypopneas, and oxygen desaturation but flow limitations showed an abnormal sleep electroencephalogram.</p>
<p>It should be reminded that an AHI value cannot be the sole determinant in evaluating and showing all aspects of SBD in children.<sup><xref ref-type="bibr" rid="bibr26-0194599813490892">26</xref></sup> Considering the above-mentioned results, further studies will be needed to evaluate the effect and usefulness of flow limitation on UARS/RERA in a control group (AHI &lt;1).</p>
<p>To our knowledge, this is the first study to examine the correlation between flow limitation and adenotonsillar size. However, this study had several limitations. First, the sample size was modest. In particular, because of the modest number of patients in each OSAS subgroup, especially the moderate OSAS subgroup, the statistical power of this study may be relatively low. To compensate for this problem, we classified the OSAS group into 2 subgroups such as mild and moderate to severe according to severity of the AHI. Second, the effect of ATH on mouth breathing was not considered. For all subjects in this study, although both oral thermistor and nasal pressure transducers were used, the measurement of flow limitation with the oral thermistor has not been established, so if subjects breathed through an oral airway partially or totally, the measurement of flow limitation with the nasal pressure transducer might have been affected. Third, the cutoff value (%) for abnormal flow limitations and the effects of mouth breathing on flow limitation were not evaluated.</p>
</sec>
<sec id="section16-0194599813490892" sec-type="conclusions">
<title>Conclusion</title>
<p>Although our data suggest that the larger the adenotonsillar size, the greater the chance of having SDB, adenotonsillar size did not predict the severity of AHI. Nevertheless, adenoid size might be related to the lowest oxygen saturation, which is thought to be related to subjective symptoms (KOSA-18). Although in the control group (AHI &lt;1), flow limitation was related to tonsil size but not to QOL (KOSA-18), further research to understand the roles of flow limitation, RERA, and UARS in the pediatric population needs to be done.</p>
</sec>
<sec id="section17-0194599813490892">
<title>Author Contributions</title>
<p><bold>Se-Hwan Hwang</bold>, study conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Christian Guilleminault</bold>, study conception and design, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Chan-Soon Park</bold>, study conception and design, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Tae-Won Kim</bold>, acquisition of data, analysis and interpretation of data, drafting the article and revisions, final approval of article; <bold>Seung-Chul Hong</bold>, analysis and interpretation of data, drafting the article and revisions, final approval of article.</p>
</sec>
<sec id="section18-0194599813490892">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> Alumni of the Department of Otolaryngology–Head and Neck Surgery, The Catholic University of Korea, College of Medicine; St Vincent’s Hospital, a research institute of medical science; and the Catholic Medical Center Research Foundation. Statistical consultation was supported by the Catholic Research Coordinating Center of the Korea Health 21 R&amp;D Project (A070001), Ministry of Health &amp; Welfare, Republic of Korea.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813490892">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ali</surname><given-names>NJ</given-names></name>
<name><surname>Pitson</surname><given-names>DJ</given-names></name>
<name><surname>Stradling</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Snoring, sleep disturbance, and behaviour in 4-5 year olds</article-title>. <source>Arch Dis Child</source>. <year>1993</year>;<volume>68</volume>:<fpage>360</fpage>-<lpage>366</lpage>.</citation>
</ref>
<ref id="bibr2-0194599813490892">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chhangani</surname><given-names>BS</given-names></name>
<name><surname>Melgar</surname><given-names>T</given-names></name>
<name><surname>Patel</surname><given-names>D</given-names></name>
</person-group>. <article-title>Pediatric obstructive sleep apnea</article-title>. <source>Indian J Pediatr</source>. <year>2010</year>;<volume>77</volume>:<fpage>81</fpage>-<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr3-0194599813490892">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frank</surname><given-names>Y</given-names></name>
<name><surname>Kravath</surname><given-names>RE</given-names></name>
<name><surname>Pollak</surname><given-names>CP</given-names></name>
<name><surname>Weitzman</surname><given-names>ED</given-names></name>
</person-group>. <article-title>Obstructive sleep apnea and its therapy: clinical and polysomnographic manifestations</article-title>. <source>Pediatrics</source>. <year>1983</year>;<volume>71</volume>:<fpage>737</fpage>-<lpage>742</lpage>.</citation>
</ref>
<ref id="bibr4-0194599813490892">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenfeld</surname><given-names>M</given-names></name>
<name><surname>Tauman</surname><given-names>R</given-names></name>
<name><surname>DeRowe</surname><given-names>A</given-names></name>
<name><surname>Sivan</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Obstructive sleep apnea syndrome due to adenotonsillar hypertrophy in infants</article-title>. <source>Int J Pediatr Otorhinolaryngol</source>. <year>2003</year>;<volume>67</volume>:<fpage>1055</fpage>-<lpage>1060</lpage>.</citation>
</ref>
<ref id="bibr5-0194599813490892">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcus</surname><given-names>CL</given-names></name>
<name><surname>Brooks</surname><given-names>LJ</given-names></name>
<name><surname>Draper</surname><given-names>KA</given-names></name>
<etal/>
</person-group>. <article-title>Diagnosis and management of childhood obstructive sleep apnea syndrome</article-title>. <source>Pediatrics</source>. <year>2012</year>;<volume>130</volume>:<fpage>e714</fpage>-<lpage>e755</lpage>.</citation>
</ref>
<ref id="bibr6-0194599813490892">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montgomery-Downs</surname><given-names>HE</given-names></name>
<name><surname>O’Brien</surname><given-names>LM</given-names></name>
<name><surname>Holbrook</surname><given-names>CR</given-names></name>
<name><surname>Gozal</surname><given-names>D</given-names></name>
</person-group>. <article-title>Snoring and sleep-disordered breathing in young children: subjective and objective correlates</article-title>. <source>Sleep</source>. <year>2004</year>;<volume>27</volume>:<fpage>87</fpage>-<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr7-0194599813490892">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brietzke</surname><given-names>SE</given-names></name>
<name><surname>Gallagher</surname><given-names>D</given-names></name>
</person-group>. <article-title>The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2006</year>;<volume>134</volume>:<fpage>979</fpage>-<lpage>984</lpage>.</citation>
</ref>
<ref id="bibr8-0194599813490892">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stoohs</surname><given-names>RA</given-names></name>
<name><surname>Knaack</surname><given-names>L</given-names></name>
<name><surname>Blum</surname><given-names>HC</given-names></name>
<name><surname>Janicki</surname><given-names>J</given-names></name>
<name><surname>Hohenhorst</surname><given-names>W</given-names></name>
</person-group>. <article-title>Differences in clinical features of upper airway resistance syndrome, primary snoring, and obstructive sleep apnea/hypopnea syndrome</article-title>. <source>Sleep Med</source>. <year>2008</year>;<volume>9</volume>:<fpage>121</fpage>-<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr9-0194599813490892">
<label>9.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Iber</surname><given-names>C</given-names></name>
<name><surname>Ancoli-Israel</surname><given-names>A</given-names></name>
<name><surname>Chesson</surname><given-names>A</given-names></name>
<name><surname>Quan</surname><given-names>SF</given-names></name>
</person-group>, <collab>for the American Academy of Sleep Medicine</collab>. <source>The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications</source>. <publisher-loc>Westchester, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr10-0194599813490892">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ayappa</surname><given-names>I</given-names></name>
<name><surname>Norman</surname><given-names>RG</given-names></name>
<name><surname>Krieger</surname><given-names>AC</given-names></name>
<etal/>
</person-group>. <article-title>Non-invasive detection of respiratory effort–related arousals (REras) by a nasal cannula/pressure transducer system</article-title>. <source>Sleep</source>. <year>2000</year>;<volume>23</volume>:<fpage>763</fpage>-<lpage>771</lpage>.</citation>
</ref>
<ref id="bibr11-0194599813490892">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>M</given-names></name>
<name><surname>Ibrahim</surname><given-names>H</given-names></name>
<name><surname>Bass</surname><given-names>L</given-names></name>
</person-group>. <article-title>Clinical staging for sleep-disordered breathing</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2002</year>;<volume>127</volume>:<fpage>13</fpage>-<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr12-0194599813490892">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujioka</surname><given-names>M</given-names></name>
<name><surname>Young</surname><given-names>LW</given-names></name>
<name><surname>Girdany</surname><given-names>BR</given-names></name>
</person-group>. <article-title>Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio</article-title>. <source>AJR Am J Roentgenol</source>. <year>1979</year>;<volume>133</volume>:<fpage>401</fpage>-<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr13-0194599813490892">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muzumdar</surname><given-names>H</given-names></name>
<name><surname>Arens</surname><given-names>R</given-names></name>
</person-group>. <article-title>Diagnostic issues in pediatric obstructive sleep apnea</article-title>. <source>Proc Am Thorac Soc</source>. <year>2008</year>;<volume>5</volume>:<fpage>263</fpage>-<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr14-0194599813490892">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guilleminault</surname><given-names>C</given-names></name>
<name><surname>Stoohs</surname><given-names>R</given-names></name>
<name><surname>Clerk</surname><given-names>A</given-names></name>
<name><surname>Cetel</surname><given-names>M</given-names></name>
<name><surname>Maistros</surname><given-names>P</given-names></name>
</person-group>. <article-title>A cause of excessive daytime sleepiness: the upper airway resistance syndrome</article-title>. <source>Chest</source>. <year>1993</year>;<volume>104</volume>:<fpage>781</fpage>-<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr15-0194599813490892">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guilleminault</surname><given-names>C</given-names></name>
<name><surname>Kirisoglu</surname><given-names>C</given-names></name>
<name><surname>Poyares</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Upper airway resistance syndrome: a long-term outcome study</article-title>. <source>J Psychiatr Res</source>. <year>2006</year>;<volume>40</volume>:<fpage>273</fpage>-<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr16-0194599813490892">
<label>16.</label>
<citation citation-type="book">
<collab>American Academy of Sleep Medicine</collab>. <source>International classification of sleep disorders: Diagnostic and coding manual</source>. <edition>2nd ed</edition>. <publisher-loc>Westchester, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2005</year>.</citation>
</ref>
<ref id="bibr17-0194599813490892">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Obstructive sleep-disordered breathing in children: new controversies, new directions</article-title> <source>Clin Chest Med</source>. <year>2003</year>;<volume>24</volume>:<fpage>261</fpage>-<lpage>282</lpage>.</citation>
</ref>
<ref id="bibr18-0194599813490892">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franco</surname><given-names>RA</given-names><suffix>Jr</suffix></name>
<name><surname>Rosenfeld</surname><given-names>RM</given-names></name>
<name><surname>Rao</surname><given-names>M</given-names></name>
</person-group>. <article-title>First place—Resident Clinical Science Award 1999. Quality of life for children with obstructive sleep apnea</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2000</year>;<volume>123</volume>:<fpage>9</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr19-0194599813490892">
<label>19.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Berry</surname><given-names>RB</given-names></name>
<name><surname>Brooks</surname><given-names>R</given-names></name>
<name><surname>Gamaldo</surname><given-names>CE</given-names></name>
<etal/>
</person-group>, <collab>for the American Academy of Sleep Medicine</collab>. <source>The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0</source>. <publisher-loc>Darien, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2012</year>.</citation>
</ref>
<ref id="bibr20-0194599813490892">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>XW</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Zhou</surname><given-names>F</given-names></name>
<name><surname>Guo</surname><given-names>CK</given-names></name>
<name><surname>Huang</surname><given-names>ZT</given-names></name>
</person-group>. <article-title>Association of body position with sleep architecture and respiratory disturbances in children with obstructive sleep apnea</article-title>. <source>Acta Otolaryngol</source>. <year>2007</year>;<volume>127</volume>:<fpage>1321</fpage>-<lpage>1326</lpage>.</citation>
</ref>
<ref id="bibr21-0194599813490892">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Palatine tonsil size and its correlation with subjective tonsil size in patients with sleep-disordered breathing</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2010</year>;<volume>142</volume>:<fpage>921</fpage>-<lpage>922</lpage>, author reply 922.</citation>
</ref>
<ref id="bibr22-0194599813490892">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brooks</surname><given-names>LJ</given-names></name>
<name><surname>Stephens</surname><given-names>BM</given-names></name>
<name><surname>Bacevice</surname><given-names>AM</given-names></name>
</person-group>. <article-title>Adenoid size is related to severity but not the number of episodes of obstructive apnea in children</article-title>. <source>J Pediatr</source>. <year>1998</year>;<volume>132</volume>:<fpage>682</fpage>-<lpage>686</lpage>.</citation>
</ref>
<ref id="bibr23-0194599813490892">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Persak</surname><given-names>SC</given-names></name>
<name><surname>Sin</surname><given-names>S</given-names></name>
<name><surname>McDonough</surname><given-names>JM</given-names></name>
<name><surname>Arens</surname><given-names>R</given-names></name>
<name><surname>Wootton</surname><given-names>DM</given-names></name>
</person-group>. <article-title>Noninvasive estimation of pharyngeal airway resistance and compliance in children based on volume-gated dynamic MRI and computational fluid dynamics</article-title>. <source>J Appl Physiol</source>. <year>2011</year>;<volume>111</volume>:<fpage>1819</fpage>-<lpage>1827</lpage>.</citation>
</ref>
<ref id="bibr24-0194599813490892">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chervin</surname><given-names>RD</given-names></name>
<name><surname>Aldrich</surname><given-names>MS</given-names></name>
</person-group>. <article-title>Characteristics of apneas and hypopneas during sleep and relation to excessive daytime sleepiness</article-title>. <source>Sleep</source>. <year>1998</year>;<volume>21</volume>:<fpage>799</fpage>-<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr25-0194599813490892">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bahammam</surname><given-names>AS</given-names></name>
<name><surname>Tate</surname><given-names>R</given-names></name>
<name><surname>Manfreda</surname><given-names>J</given-names></name>
<name><surname>Kryger</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position</article-title>. <source>Sleep</source>. <year>1999</year>;<volume>22</volume>:<fpage>592</fpage>-<lpage>598</lpage>.</citation>
</ref>
<ref id="bibr26-0194599813490892">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>MC</given-names></name>
<name><surname>Guilleminault</surname><given-names>C</given-names></name>
</person-group>. <article-title>Chronic snoring and sleep in children: a demonstration of sleep disruption</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>118</volume>:<fpage>e741</fpage>-<lpage>e746</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>